Gemox: a widely useful therapy against solid tumors-review and personal experience. - Wikidata - awgldk - TriplyDB

Gemox: a widely useful therapy against solid tumors-review and personal experience.

Gemox: a widely useful therapy against solid tumors-review and personal experience.

http://www.wikidata.org/entity/Q37814700

about

Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy.

P2860

Q33670961-8BD2310E-E198-4EF9-9324-327F5BD28AB0 Q38856634-E94253BD-B9E4-4C8F-8A05-839EC777F42A

P2860

Gemox: a widely useful therapy against solid tumors-review and personal experience.

http://www.wikidata.org/entity/Q37814700

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Gemox: a widely useful therapy against solid tumors-review and personal experience.

@en

Gemox: a widely useful therapy against solid tumors-review and personal experience.

@nl

type

label

Gemox: a widely useful therapy against solid tumors-review and personal experience.

@en

Gemox: a widely useful therapy against solid tumors-review and personal experience.

@nl

prefLabel

Gemox: a widely useful therapy against solid tumors-review and personal experience.

@en

Gemox: a widely useful therapy against solid tumors-review and personal experience.

@nl

P1433

Q37814700-0377EBE4-18F8-463F-B585-37198414C86A

P1476

Q37814700-CE85F0ED-9203-435F-8DED-CE43E12340AB

P2093

Q37814700-29039518-43C1-4ADD-953B-E8E51E2A7BA1

Q37814700-98406F21-7AA0-4468-82C2-B0A4E0D3289A

P2860

Q37814700-051B95E5-47BD-4371-AA9E-DC239261C261

Q37814700-06D75FF8-29E0-4603-A57B-04F77510E63A

Q37814700-0E05EA17-F332-4FFD-9DB2-056F90F93BDE

Q37814700-12B1C9BA-1CDC-422C-AA14-7EA9B3EA5E12

Q37814700-1A90EE48-E3D1-46E5-92B9-C82D922BB118

Q37814700-1CBDE69C-5C5C-44D3-B234-4108F169911D

Q37814700-26CC2710-72B3-420E-AB66-91F45DE1A2B7

Q37814700-29CCE73D-CAFD-40E1-881E-61784492B886

Q37814700-2FC47B73-FDCD-4D36-B8A3-51D4F64DBBC2

Q37814700-38DF7A5B-095A-44CF-B4FA-393E3FB7855C

P304

Q37814700-B24B0301-A4F6-4035-9569-479A722023E3

P31

Q37814700-0f09e6d8-9e90-451d-95a1-ae513d864332

Q37814700-1737777F-ACC8-4D60-94CF-3090E978A361

P356

Q37814700-E5E1EF3C-5749-4C7A-9169-A4F5669A24BB

P433

Q37814700-2B2EE84A-128E-410E-9F06-064B85188C1D

P478

Q37814700-BC9CFCB1-4E18-4760-BBE7-C16C21773685

P577

Q37814700-F4684A25-01FD-422E-9AC1-6427B4EEFEEC

P698

Q37814700-3E422414-A1C0-44EF-9C33-D42EE01EB7BD

P356

JOC.2010.22.5.298

P1433

Journal of Chemotherapy

P1476

Gemox: a widely useful therapy against solid tumors-review and personal experience.

@en

P2093

A Zaniboni

http://www.w3.org/2001/XMLSchema#string

F Meriggi

http://www.w3.org/2001/XMLSchema#string

P2860

Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes: clinical and pharmacokinetic data.

Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients.

Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma.

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients.

Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.

Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.

Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study.

P304

298-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/JOC.2010.22.5.298

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21123151

http://www.w3.org/2001/XMLSchema#string